{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:25:24Z","timestamp":1772306724215,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005782","name":"Nara Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005782","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.clineuro.2025.108919","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T15:50:56Z","timestamp":1745596256000},"page":"108919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Association between adiponectin and lipids in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"254","author":[{"given":"Mayu","family":"Sugata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4157-5447","authenticated-orcid":false,"given":"Hiroshi","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Sugie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2025.108919_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MOL.0b013e32814a645f","article-title":"Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease","volume":"18","author":"Lara-Castro","year":"2007","journal-title":"Curr. Opin. Lipido"},{"key":"10.1016\/j.clineuro.2025.108919_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12974-016-0530-x","article-title":"Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research","volume":"13","author":"Parimisetty","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.clineuro.2025.108919_bib3","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.STR.0000217384.03237.9c","article-title":"Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study","volume":"37","author":"Scigliano","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2025.108919_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1476-5381.2011.01560.x","article-title":"Adiponectin receptor signalling in the brain","volume":"165","author":"Thundyil","year":"2012","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.clineuro.2025.108919_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/00207454.2013.846340","article-title":"Adiponectin offers protection against L166P mutant DJ-1-induced neuronal cytotoxicity mediated by APPL1-dependent AMPK activation","volume":"124","author":"Li","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.clineuro.2025.108919_bib6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/acn3.77","article-title":"Disease-modifying effect of adiponectin in model of \u03b1-synucleinopathies","volume":"1","author":"Sekiyama","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.clineuro.2025.108919_bib7","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.metabol.2012.06.001","article-title":"Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease","volume":"61","author":"Li","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.clineuro.2025.108919_bib8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.STR.0000217384.03237.9c","article-title":"Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study","volume":"37","author":"Scigliano","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2025.108919_bib9","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s10072-019-04216-4","article-title":"Serum adiponectin levels between patients with Parkinson's disease and those with PSP","volume":"41","author":"Kataoka","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clineuro.2025.108919_bib10","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/mds.28536","article-title":"Changes in body composition before and after parkinson\u2019s disease diagnosis","volume":"36","author":"Song","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clineuro.2025.108919_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nature05026","article-title":"Central nervous system control of food intake and body weight","volume":"443","author":"Morton","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.clineuro.2025.108919_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02251202","article-title":"Increased prevalence of undernutrition in Parkinson's disease and its relationship to clinical disease parameters","volume":"5","author":"Markus","year":"1993","journal-title":"J. Neural Transm. Park Dis. Dement Sect."},{"key":"10.1016\/j.clineuro.2025.108919_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/cs0830199","article-title":"Raised resting energy expenditure in Parkinson's disease and its relationship to muscle rigidity","volume":"83","author":"Markus","year":"1992","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.clineuro.2025.108919_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025537","article-title":"Dopamine receptors in human adipocytes: expression and functions","volume":"6","author":"Borcherding","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clineuro.2025.108919_bib15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/ene.13844","article-title":"Levodopa\/carbidopa intestinal gel infusion and weight loss in Parkinson's disease","volume":"26","author":"Fabbri","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2025.108919_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clineuro.2025.108919_bib17","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/mds.23192","article-title":"Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry","volume":"25","author":"K\u00f6llensperger","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clineuro.2025.108919_bib18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2025.108919_bib19","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Movement disorder Society-endorsed PSP Study Group, Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clineuro.2025.108919_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cca.2006.03.008","article-title":"Determination of adiponectin in serum using a latex particle-enhanced turbidimetric immunoassay with an automated analyzer","volume":"371","author":"Nishimura","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clineuro.2025.108919_bib21","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mds.29410","article-title":"Levodopa dose equivalency in parkinson's disease: updated systematic review and proposals","volume":"38","author":"Jost","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clineuro.2025.108919_bib22","article-title":"Serum adiponectin levels in advanced-stage Parkinson's disease patients","volume":"2011","author":"Cassani","year":"2011","journal-title":"Park. Dis."},{"key":"10.1016\/j.clineuro.2025.108919_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fnins.2018.00128","article-title":"Estrogen interactions with lipid rafts related to neuroprotection. Impact of brain ageing and menopause","volume":"12","author":"Marin","year":"2018","journal-title":"Front Neurosci."},{"key":"10.1016\/j.clineuro.2025.108919_bib24","doi-asserted-by":"crossref","first-page":"20689","DOI":"10.1073\/pnas.1902958116","article-title":"Parkinson's disease-associated iPLA2-VIA\/ PLA2G6 regulates neuronal functions and \u03b1-synuclein stability through membrane remodeling","volume":"116","author":"Yamashita","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.clineuro.2025.108919_bib25","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","article-title":"Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease","volume":"17","author":"Fabelo","year":"2011","journal-title":"Mol. Med"},{"key":"10.1016\/j.clineuro.2025.108919_bib26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.jnen.0000179050.54522.5a","article-title":"Evidence of oxidative stress in the neocortex in incidental Lewy body disease","volume":"64","author":"Dalf\u00f3","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.clineuro.2025.108919_bib27","doi-asserted-by":"crossref","first-page":"34328","DOI":"10.1074\/jbc.M004345200","article-title":"Alpha-Synuclein membrane interactions and lipid specificity","volume":"275","author":"Jo","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clineuro.2025.108919_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/srep17625","article-title":"Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson's disease patients","volume":"5","author":"Araki","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clineuro.2025.108919_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neurobiolaging.2016.08.027","article-title":"Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases","volume":"49","author":"Marin","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.clineuro.2025.108919_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.mce.2010.11.002","article-title":"The crosstalks between adipokines and catecholamines","volume":"332","author":"Than","year":"2011","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.clineuro.2025.108919_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in Parkinson's disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.clineuro.2025.108919_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12974-016-0530-x","article-title":"Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research","volume":"13","author":"Parimisetty","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.clineuro.2025.108919_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diabetes.55.01.06.db05-1077","article-title":"Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells","volume":"55","author":"Spranger","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.clineuro.2025.108919_bib34","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","article-title":"Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis","volume":"73","author":"Qin","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clineuro.2025.108919_bib35","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s00221-017-4978-4","article-title":"Cathepsin S increases tau oligomer formation through limited cleavage, but only IL-6, not cathespin S serum levels correlate with disease severity in the neurodegenerative tauopathy progressive supranuclear palsy","volume":"235","author":"N\u00fcbling","year":"2017","journal-title":"Exp. Brain Res"},{"key":"10.1016\/j.clineuro.2025.108919_bib36","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1210\/jc.2005-2714","article-title":"Adiponectin in umbilical cord blood is inversely related to low-density lipoprotein cholesterol but not ethnicit","volume":"91","author":"Bansal","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clineuro.2025.108919_bib37","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/obr.12064","article-title":"Adiponectin and lipoprotein metabolism","volume":"14","author":"Christou","year":"2013","journal-title":"Obes. Rev."},{"key":"10.1016\/j.clineuro.2025.108919_bib38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.14310\/horm.2002.1345","article-title":"High density lipoprotein is positively correlated with the changes in circulating total adiponectin and high molecular weight adiponectin during dietary and fenofibrate treatment","volume":"11","author":"Christou","year":"2012","journal-title":"Horm. (Athens)"},{"key":"10.1016\/j.clineuro.2025.108919_bib39","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/jn\/135.11.2499","article-title":"Comparative aspects of lipid metabolism: impact on contemporary research and use of animal models","volume":"135","author":"Bergen","year":"2005","journal-title":"J. Nutr."},{"key":"10.1016\/j.clineuro.2025.108919_bib40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbrc.2011.06.131","article-title":"Possibility of increasing cholesterol efflux by adiponectin and its receptors through the ATP binding cassette transporter A1 in HEK293T cells","volume":"411","author":"Kitajima","year":"2011","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.clineuro.2025.108919_bib41","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.atherosclerosis.2010.01.001","article-title":"Impact of HDL on adipose tissue metabolism and adiponectin expression","volume":"210","author":"Van Linthout","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clineuro.2025.108919_bib42","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/mds.21068","article-title":"Body weight in patients with Parkinson's disease","volume":"21","author":"Bachmann","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clineuro.2025.108919_bib43","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0002-8223(95)00269-3","article-title":"Weight change and body composition in patients with Parkinson's disease","volume":"95","author":"Beyer","year":"1995","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.clineuro.2025.108919_bib44","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ana.10577","article-title":"Weight loss in Parkinson's disease","volume":"53","author":"Chen","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clineuro.2025.108919_bib45","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1468-1331.2009.02617.x","article-title":"Dopaminergic treatment is associated with decreased body weight in patients with Parkinson's disease and dyskinesias","volume":"16","author":"Bachmann","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2025.108919_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1385\/ENDO:29:1:81","article-title":"Adipocyte-derived hormones, cytokines, and mediators","volume":"29","author":"Rondinone","year":"2006","journal-title":"Endocrine"},{"key":"10.1016\/j.clineuro.2025.108919_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2009.07.031","article-title":"Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome","volume":"314","author":"Maury","year":"2010","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.clineuro.2025.108919_bib48","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1210\/jc.2003-031777","article-title":"Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies","volume":"89","author":"Baratta","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clineuro.2025.108919_bib49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.parkreldis.2008.04.036","article-title":"Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease","volume":"15","author":"Scigliano","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.clineuro.2025.108919_bib50","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0003-2697(81)90795-8","article-title":"Differential assay of arylsulfatase A and B activities: a sensitive method for cultured human cells","volume":"117","author":"Chang","year":"1981","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.clineuro.2025.108919_bib51","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/npp.2010.21","article-title":"Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis","volume":"35","author":"Maayan","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clineuro.2025.108919_bib52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2010.04.003","article-title":"The tempted brain eats: pleasure and desire circuits in obesity and eating disorders","volume":"1350","author":"Berridge","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.clineuro.2025.108919_bib53","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3390\/ijms20051190","article-title":"Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives","volume":"20","author":"Yanai","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clineuro.2025.108919_bib54","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.metabol.2003.12.008","article-title":"Serum adiponectin is associated with high-density lipoprotein cholesterol, triglycerides, and low-density lipoprotein particle size in young healthy men","volume":"53","author":"Kazumi","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.clineuro.2025.108919_bib55","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijcard.2004.03.050","article-title":"Reciprocal association between visceral obesity and adiponectin: in healthy premenopausal women","volume":"101","author":"Kwon","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.clineuro.2025.108919_bib56","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s13760-017-0798-3","article-title":"CSF concentrations of adipsin and adiponectin in patients with amyotrophic lateral sclerosis","volume":"117","author":"Mart\u00ednez","year":"2017","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.clineuro.2025.108919_bib57","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.2337\/diabetes.51.9.2734","article-title":"Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte- derived protein","volume":"51","author":"Nishizawa","year":"2002","journal-title":"Diabetes"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725002021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725002021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T14:14:58Z","timestamp":1748009698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846725002021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":57,"alternative-id":["S0303846725002021"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.108919","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between adiponectin and lipids in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.108919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108919"}}